An Evaluation of the Safety and Efficacy of Methylone for PTSD
This summary needs review. Please check the official study record and contact the research team for details.
In United Kingdom
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This summary needs review. Please check the official study record and contact the research team for details.
In United KingdomThis study is completed in the United Kingdom. It focuses on Depression.
In United KingdomThis summary needs review. Please check the official study record and contact the research team for details.
In United KingdomThis summary needs review. Please check the official study record and contact the research team for details.
In United KingdomThis study exists to see whether the medication Asenapine can make care clearer and more responsive. Researchers are trying to understand whether the medication Asenapine can give earlier or clearer feedback during care.
In United KingdomThis summary needs review. Please check the official study record and contact the research team for details.
Remote / onlineThis study is completed in the United Kingdom. It is testing GSK618334 for Addiction.
In United KingdomThis study is completed in the United Kingdom, in the Netherlands, in Czechia, .... It focuses on PTSD.
In United KingdomThis study is completed in the United Kingdom, in Belgium, in Germany, .... It is testing intranasal Esketamine for treatment-resistant depression.
In United KingdomThis study is completed in the United Kingdom, in Sweden, in Denmark, .... It focuses on Addiction.
In United KingdomThis study is completed in the United States, in the United Kingdom, in Croatia, .... It focuses on schizophrenia.
In United KingdomThis study is completed in the United Kingdom, in Belgium, in Sweden, .... It is testing intranasal Esketamine for treatment-resistant depression.
In United KingdomHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.